Motor Cortex Stimulation for Facial Pain.

Q2 Medicine

Progress in neurological surgery Pub Date : 2020-01-01 Epub Date: 2020-09-29 DOI:10.1159/000509909

Zoe E Teton, Ahmed M Raslan

引用次数: 0

Abstract

Motor cortex stimulation (MCS) has been used in the treatment of intractable neuropathic facial pain for nearly 30 years. While efficacy rates have been noted as high as 88% in some studies, considerable variability in treatment response remains. Additionally, MCS is often cited as providing diminishing relief over time, and there are few long-term studies on efficacy. Complications are generally mild and include infection, hardware complication, seizure, and transient neurological deficit. Despite relatively minimal use, MCS remains a viable treatment option for the appropriately selected facial pain patients that have proved refractory to conservative management.

查看原文本刊更多论文

运动皮质刺激治疗面部疼痛。

运动皮质刺激(MCS)用于治疗难治性神经性面部疼痛已有近30年的历史。虽然在一些研究中有效率高达88%，但在治疗反应方面仍然存在相当大的差异。此外，MCS通常被认为随着时间的推移提供的缓解作用逐渐减弱，并且很少有关于疗效的长期研究。并发症通常是轻微的，包括感染、硬件并发症、癫痫发作和短暂性神经功能障碍。尽管使用相对较少，MCS仍然是一个可行的治疗选择，适当选择的面部疼痛患者已证明难以保守管理。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Progress in neurological surgery Medicine-Surgery

自引率

0.00%

发文量

期刊介绍： Published since 1966, this series has become universally recognized as the most significant group of books serving neurological surgeons. Volumes feature contributions from distinguished international surgeons, who brilliantly review the literature from the perspective of their own personal experience. The result is a series of works providing critical distillations of developments of central importance to the theory and practice of neurological surgery.